Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

GFS Mark II inflatable penile prosthesis: four-year clinical study

R L Fein1

  • 1Potency, Inc., North Miami, Florida.

Urology
|February 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The G.F.S. Mark II inflatable penile prosthesis.

The Journal of urology·1992
Same author

Duraphase penile prosthesis dorsal approach using local anesthesia.

Urology·1991
Same author

Mentor GFS inflatable prosthesis.

Urology·1990
Same author

Intracavernous medication for treatment of premature ejaculation.

Urology·1990
Same author

Classification of sexual dysfunction for management of intracavernous medication-induced erections.

The Journal of urology·1990
Same author

Clinical evaluation of inflatable penile prosthesis with combined pump-reservoir.

Urology·1988
Same journal

Editorial Comment on "A Histopathologic Assessment of Prostate Ductal Anatomy in Relation to Micro-Ultrasound".

Urology·2026
Same journal

Same-Day Discharge Following Multiport Robot-Assisted Simple Prostatectomy: A Prospective Feasibility Study of Outcomes, Costs, and Post-Discharge Healthcare Utilization.

Urology·2026
Same journal

Extended versus Standard Lymph Node Dissection at the Time of Radical Cystectomy for Bladder Cancer.

Urology·2026
Same journal

Intractable Epistaxis and Severe Hypertension in a Young Woman.

Urology·2026
Same journal

A 53-Year-Old Man with Elevated PSA and a Cystic Pelvic Lesion.

Urology·2026
Same journal

Low-Grade, Papillary Bladder Tumors A plea for in-office fulguration.

Urology·2026
See all related articles

The GFS Mark II inflatable penile prosthesis (IPP) demonstrated excellent mechanical performance with minimal issues. High patient and partner satisfaction rates were reported, highlighting its effectiveness.

Area of Science:

  • Urology
  • Medical Devices
  • Prosthetics

Background:

  • Erectile dysfunction affects a significant number of men, necessitating effective treatment options.
  • Inflatable penile prostheses (IPPs) are a common surgical solution for severe erectile dysfunction.
  • The GFS Mark II IPP is a specific model designed to improve upon existing IPP technology.

Purpose of the Study:

  • To assess the mechanical reliability of the GFS Mark II inflatable penile prosthesis (IPP).
  • To evaluate patient and partner satisfaction with the GFS Mark II IPP.
  • To identify any potential complications or areas for improvement.

Main Methods:

  • A cohort of 138 patients receiving GFS Mark II IPP implants between 1988 and 1991 were followed for 12-50 months.

Related Experiment Videos

  • Prosthesis performance was evaluated through patient assessments.
  • Patient and partner satisfaction was measured using questionnaires and interviews.
  • Main Results:

    • A single mechanical issue was reported involving the prosthesis tubing.
    • Two postoperative infections occurred among seven reported problems requiring explanation.
    • Ninety-three percent of patients and 98% of partners reported satisfaction with the GFS Mark II IPP.
    • The resipump feature allowed for office-based fluid volume adjustment in 13 patients.

    Conclusions:

    • The GFS Mark II connectorless IPP exhibits a low rate of mechanical complications over a four-year period.
    • High patient and partner satisfaction underscores the efficacy of the GFS Mark II IPP.
    • The integrated resipump offers a practical advantage for fluid volume management.